Johnson DB - Search Results

1

High-dose melphalan with autotransplantation for refractory multiple myeloma: results of a Southwest Oncology Group phase II trial.

Vesole DH, Crowley JJ, Catchatourian R, Stiff PJ, Johnson DB, Cromer J, Salmon SE, Barlogie B. Vesole DH, et al. Among authors: johnson db. J Clin Oncol. 1999 Jul;17(7):2173-9. doi: 10.1200/JCO.1999.17.7.2173. J Clin Oncol. 1999. PMID: 10561273 Clinical Trial.

2

Phase II trial of high-dose melphalan and autologous bone marrow transplantation for metastatic colon carcinoma.

Leff RS, Thompson JM, Johnson DB, Mosley KR, Daly MB, Knight WA 3rd, Ruxer RL Jr, Messerschmidt GL. Leff RS, et al. Among authors: johnson db. J Clin Oncol. 1986 Nov;4(11):1586-91. doi: 10.1200/JCO.1986.4.11.1586. J Clin Oncol. 1986. PMID: 3534154

3

Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation.

Johnson DB, Thompson JM, Corwin JA, Mosley KR, Smith MT, de los Reyes RA, Daly MB, Petty AM, Lamaster D, Pierson WP, et al. Johnson DB, et al. J Clin Oncol. 1987 May;5(5):783-9. doi: 10.1200/JCO.1987.5.5.783. J Clin Oncol. 1987. PMID: 3553437

4

Carmustine, Ara C, cyclophosphamide and etoposide with autologous bone marrow transplantation in relapsed or refractory lymphoma: a dose-finding study.

Snyder MJ, Johnson DB, Daly MB, Giguere JK, Harman GH, Harden EA, Johnson RA, Leff RS, Mercier RJ, Messerschmidt GL, et al. Snyder MJ, et al. Among authors: johnson ra, johnson db. Bone Marrow Transplant. 1994 Oct;14(4):595-600. Bone Marrow Transplant. 1994. PMID: 7858534

5

Acute neurologic dysfunction after high-dose etoposide therapy for malignant glioma.

Leff RS, Thompson JM, Daly MB, Johnson DB, Harden EA, Mercier RJ, Messerschmidt GL. Leff RS, et al. Among authors: johnson db. Cancer. 1988 Jul 1;62(1):32-5. doi: 10.1002/1097-0142(19880701)62:1<32::aid-cncr2820620108>3.0.co;2-x. Cancer. 1988. PMID: 3289726

6

Corrigendum to 'Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States' [Clinical Lymphoma, Myeloma, and Leukemia Volume 24, Issue 8, August 2024, Pages 523-530].

Lurain K, El Zarif T, Ramaswami R, Nassar AH, Adib E, Abdel-Wahab N, Chintapally N, Drolen CE, Feldman T, Haykal T, Nebhan CA, Kambhampati S, Li M, Mittra A, Lorentsen M, Kim C, Drakaki A, Morse M, Johnson DB, Mangla A, Dittus C, Ravi P, Baiocchi RA, Chiao EY, Rubinstein PG, Yellapragada SV, LaCasce AS, Sonpavde GP, Naqash AR, Herrera AF. Lurain K, et al. Among authors: johnson db. Clin Lymphoma Myeloma Leuk. 2024 Dec;24(12):873. doi: 10.1016/j.clml.2024.10.011. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39603773 No abstract available.

7

Immune checkpoint inhibition of metastatic melanoma: achieving high efficacy in the face of high toxicity.

Justice J, Kankaria RA, Johnson DB. Justice J, et al. Among authors: johnson db. Expert Rev Clin Pharmacol. 2024 Nov 21:1-11. doi: 10.1080/17512433.2024.2431513. Online ahead of print. Expert Rev Clin Pharmacol. 2024. PMID: 39570086 Review.

8

Management of severe immune-related adverse events and outcomes in patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors.

Naidoo J, Johnson DB, Doran C, Wang Y, Zhang Y, Le TK, Hopson S, Dreyfus B, Lal LS, Vyas C, Goldstein S, Izadi Z. Naidoo J, et al. Among authors: johnson db. Oncologist. 2024 Nov 20:oyae318. doi: 10.1093/oncolo/oyae318. Online ahead of print. Oncologist. 2024. PMID: 39566081 Free article.

9

Exploring Computational Advancements in ADME: Essential Insights for Drug Disposition.

Johnson DB, Singh G, Sharma D, Natarajan V, Lakshmi KC, Dhakar RC, Shahi SR, Velayutham S, Tiwari R. Johnson DB, et al. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2024 Nov 4;40:e20240033. doi: 10.62958/j.cjap.2024.033. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2024. PMID: 39496312 Free article. Review.

10

Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy.

Woodford R, McKeown J, Hoeijmakers LL, Mangana J, Dimitriou F, Allayous C, Zaman F, Aya F, Marsiglio J, Goodman R, Rayson V, Placzke J, Kessels J, Ramalyte E, Haque W, Wilson I, Trojaniello C, Benannoune N, Roberts-Thomson R, Robert C, Blank CU, Dummer R, Lebbe C, Haydon A, Arance A, Hu-Lieskovan S, Johnson DB, Mcarthur GA, Rutkowski P, Neyns B, Sullivan RJ, Weber J, Carlino MS, Ascierto PA, Lo S, Long GV, Menzies AM. Woodford R, et al. Among authors: johnson db. Eur J Cancer. 2024 Nov;212:115055. doi: 10.1016/j.ejca.2024.115055. Epub 2024 Sep 29. Eur J Cancer. 2024. PMID: 39366209

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

677 results

Search Page

Filters